Electronic Batch Records

Generics Organizations that do their own drug or API manufacturing recognise that the primary bottleneck in releasing a batch to market is the time and effort required to build the master batch record (MBR) after the processing steps have been completed. The goal for manufacturing divisions is to minimize the manual steps that slow down the process and also affect the accuracy and completeness of the information.

By utilizing the automated QUMAS Electronic Batch Record solution manufacturing divisions can benefit from:

  • Reduced cycle time
  • Reduced inventory
  • Reduced data entry errors
  • Improved visibility of production and process exceptions
  • Rapid return on investment

For more information on the QUMAS eBR Solution based on QUMAS ProcessCompliance, please contact info@qumas.com

Watch these webinars to learn more about the changes in the regulation of the Generics Industry, and how to address them:

Submission Management in the World of Generic Manufacturing

How Generic Drug Manufacturers can Reduce Cost and Time to Market with a Global EDMS/QMS